D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
GSK holding history
GSK plc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,019,449
- Value
- $53.4M
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,019,449 | $53.4M | <0.1% | +1,019,449 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −5,544−100.0% | Sold out | Holders |
| Q4 2025 | 5,544 | $271.9K | <0.1% | +5,544 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −114,110−100.0% | Sold out | Holders |
| Q4 2024 | 114,110 | $3.86M | <0.1% | −8,746−7.1% | Reduced | Holders |
| Q3 2024 | 122,856 | $5.02M | <0.1% | +122,856 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −25,200−100.0% | Sold out | Holders |
| Q3 2023 | 25,200 | $913.5K | <0.1% | −194,461−88.5% | Reduced | Holders |
| Q2 2023 | 219,661 | $7.83M | <0.1% | +219,661 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −117,760−100.0% | Sold out | Holders |
| Q2 2022 | 117,760 | $5.13M | <0.1% | −387,177−76.7% | Reduced | Holders |
| Q1 2022 | 504,937 | $22.0M | <0.1% | −228,893−31.2% | Reduced | Holders |
| Q4 2021 | 733,830 | $32.4M | <0.1% | +719,141+4,895.8% | Added | Holders |
| Q3 2021 | 14,689 | $561.0K | <0.1% | +4,964+51.0% | Added | Holders |
| Q2 2021 | 9,725 | $387.0K | <0.1% | +9,725 | New | Holders |